Literature DB >> 15995155

Sleep disturbance and depression as barriers to adherence.

Kenneth D Phillips1, Linda Moneyham, Carolyn Murdaugh, Mary R Boyd, Abbas Tavakoli, Kirby Jackson, Medha Vyavaharkar.   

Abstract

This study examined the relationships among subjective sleep disturbance, depressive symptoms, and adherence to medications among HIV-infected women. HIV-infected women (N = 173) were recruited through community AIDS service organizations throughout South Carolina. Participants completed the Pittsburgh Sleep Quality Index (PSQI), the Centers for Epidemiological Studies Depression Scale (CES-D), and a modified version of the Adults AIDS Clinical Trials Group Adherence Baseline Questionnaire. Women who reported greater sleep disturbance also reported a higher level of depressive symptoms and reported poor adherence to their medication regimen. Depression helped to explain the relationship between sleep quality and adherence. Results indicate that assessment and management of sleep disturbance and depressive symptoms in women with HIV disease is important to promote medication adherence.

Entities:  

Mesh:

Year:  2005        PMID: 15995155     DOI: 10.1177/1054773805275122

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  37 in total

1.  Research results have expiration dates: ensuring timely systematic reviews.

Authors:  Julie Barroso; Margarete Sandelowski; Corrine I Voils
Journal:  J Eval Clin Pract       Date:  2006-08       Impact factor: 2.431

Review 2.  In or out? Methodological considerations for including and excluding findings from a meta-analysis of predictors of antiretroviral adherence in HIV-positive women.

Authors:  Corrine I Voils; Julie Barroso; Victor Hasselblad; Margarete Sandelowski
Journal:  J Adv Nurs       Date:  2007-06-03       Impact factor: 3.187

3.  Engagement in Care, Psychological Distress, and Resilience are Associated with Sleep Quality among HIV-Positive Gay, Bisexual, and Other Men Who Have Sex with Men.

Authors:  Martin J Downing; Steven T Houang; Roberta Scheinmann; Irene S Yoon; Mary Ann Chiasson; Sabina Hirshfield
Journal:  Sleep Health       Date:  2016-09-19

4.  Anxiety sensitivity in relation to sleep quality among HIV-infected individuals.

Authors:  Teresa M Leyro; Kimberly A Babson; Marcel O Bonn-Miller
Journal:  J Assoc Nurses AIDS Care       Date:  2014-04-20       Impact factor: 1.354

Review 5.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Association Between Health Literacy and Medication Adherence Among Hispanics with Hypertension.

Authors:  Maichou Lor; Theresa A Koleck; Suzanne Bakken; Sunmoo Yoon; Ann-Margaret Dunn Navarra
Journal:  J Racial Ethn Health Disparities       Date:  2019-01-03

7.  Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.

Authors:  David B Hanna; Nancy A Hessol; Elizabeth T Golub; Jennifer M Cocohoba; Mardge H Cohen; Alexandra M Levine; Tracey E Wilson; Mary Young; Kathryn Anastos; Robert C Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

8.  A Bayesian method for the synthesis of evidence from qualitative and quantitative reports: the example of antiretroviral medication adherence.

Authors:  Corrine Voils; Vic Hassselblad; Jamie Crandell; Yunkyung Chang; Eunjeong Lee; Margarete Sandelowski
Journal:  J Health Serv Res Policy       Date:  2009-10

9.  A pilot study of sleep quality and rest-activity patterns in persons living with HIV.

Authors:  Diana M Taibi; Cynthia Price; Joachim Voss
Journal:  J Assoc Nurses AIDS Care       Date:  2012-10-10       Impact factor: 1.354

10.  Clinical significance of mobile health assessed sleep duration and variability in bipolar disorder.

Authors:  Christopher N Kaufmann; Anda Gershon; Lisa T Eyler; Colin A Depp
Journal:  J Psychiatr Res       Date:  2016-07-09       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.